Literature DB >> 479601

Histocompatibilty-linked susceptibility for hepatospleenomegaly in human schistosomiasis mansoni.

E A Salam, S Ishaac, A A Mahmoud.   

Abstract

In schistosomiasis mansoni, the pathogenesis of hepatosplenic disease has been shown to be due primarily to immune mechanisms. The present study was designed to examine the relationship between the development of schistosomal hepatosplenomegaly in Egyptian school children and the HLA antigens. Two groups of schistosome-infected children with similar fecal egg counts were examined: one group (23 children) had no clinically demonstrable hepatosplenomegaly whereas all the children (28) in the second group suffered from liver enlargement. Furthermore, 13 of the 28 individuals in the latter group had splenomegaly as well. Our results show that hepatosplenomegaly was related to the presence of two HLA antigens: HLA AI and B5. The average relative risk of developing hepatomegaly is 29 for HLA AI and 18.9 for 55.6. Furthermore, the severity of hepatomegaly was correlated with the presence of these two HLA antigens. These findings represent a step toward elucidating the factors controlling the pathogenic mechanisms in human schistosomiasis mansoni.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 479601

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Curse of schistosomiasis on Egyptian liver.

Authors:  Abdel-Rahman El-Zayadi
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

Review 2.  Hepatosplenic schistosomiasis: a clinical review.

Authors:  K M De Cock
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

3.  Parasite immunity and the major histocompatibility complex.

Authors:  M A Vadas
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

4.  Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene.

Authors:  A J Dessein; D Hillaire; N E Elwali; S Marquet; Q Mohamed-Ali; A Mirghani; S Henri; A A Abdelhameed; O K Saeed; M M Magzoub; L Abel
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

Review 5.  Immunopathology of Schistosoma mansoni infection.

Authors:  D L Boros
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

6.  HLA class II polymorphism influences onset and severity of pathology in Schistosoma mansoni-infected transgenic mice.

Authors:  G Angyalosi; R Neveu; I Wolowczuk; A Delanoye; J Herno; C Auriault; V Pancré
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Evidence for the control of eosinophilia by the major histocompatibility complex in mice.

Authors:  W A Sewell; M A Vadas
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

8.  Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni.

Authors:  L Abel; F Demenais; A Prata; A E Souza; A Dessein
Journal:  Am J Hum Genet       Date:  1991-05       Impact factor: 11.025

9.  No evidence for a major effect of tumor necrosis factor alpha gene polymorphisms in periportal fibrosis caused by Schistosoma mansoni infection.

Authors:  Carole Eboumbou Moukoko; Nasureldin El Wali; O K Saeed; Qurashi Mohamed-Ali; Jean Gaudart; Alain J Dessein; Christophe Chevillard
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Immunogenetic analysis of patients with post-schistosomal liver cirrhosis in man.

Authors:  N Ohta; Y K Nishimura; M Iuchi; T Sasazuki
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.